🔍

CYIENTDLM - Cyient DLM

📊 NSE: CYIENTDLM 🏢 Electronics - Components 📅 Last Updated: 12/13/2025 21:18

📢 Recent Corporate Announcements

Cyient DLM Schedules Investor Meeting with MSA Capital Partners on May 14, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 06 May 2026, 11:29 AM

Cyient DLM Limited has announced a virtual meeting with MSA Capital Partners scheduled for May 14, 2026, between 11:00 AM and 12:00 PM. The company will be represented by its Chief Financial Officer, Subramanian RM, and AVP Suresh Narayan. This disclosure is a routine compliance filing under SEBI (LODR) Regulations regarding institutional investor interactions. The company has explicitly stated that no unpublished price sensitive information (UPSI) will be disclosed during this session.

Virtual meeting scheduled with MSA Capital Partners on May 14, 2026
Company representation includes CFO Subramanian RM and AVP Suresh Narayan
Interaction duration set for one hour from 11:00 AM to 12:00 PM
Formal disclosure made under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

💡 No immediate action is required as this is a routine investor engagement. Investors may look for any subsequent presentation or transcript filings if the company chooses to release them.

Cyient DLM VP & Head of Operations Mujeeb Rahiman Resigns Effective April 30, 2026

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 30 Apr 2026, 01:43 PM

Cyient DLM Limited has announced the resignation of Mr. Mujeeb Rahiman, who held the position of Vice President & Head of Operations - India. He will officially cease to be a Senior Managerial Personnel (SMP) of the company effective from the close of business hours on April 30, 2026. The company has complied with Regulation 30 of SEBI Listing Obligations and Disclosure Requirements for this disclosure. This transition marks a change in the leadership of the company's domestic operational division.

Mr. Mujeeb Rahiman has resigned as Vice President & Head of Operations - India
The resignation is effective from the close of business hours on April 30, 2026
The departure is classified as a change in Senior Managerial Personnel (SMP)
The filing was made in accordance with SEBI Circular No. SEBI/HO/CFD/CFD-PoDl/P/CIR/2023/123

💡 Investors should monitor the company's upcoming announcements for the appointment of a successor to ensure operational continuity. No immediate impact on stock performance is expected from this routine management change.

Cyient DLM Reports Strong FY26 with $208M Order Intake and 10%+ EBITDA Margins

🟢 POSITIVE ⭐ 8/10

EARNINGS 📅 27 Apr 2026, 04:02 PM

Cyient DLM reported a robust performance for FY26, achieving its highest-ever order backlog with a book-to-bill ratio of 1.5x. The company secured a total order intake exceeding $208 million during the year, driven by strong demand in Aerospace, Defense, and Automotive sectors. For the first time, EBITDA margins sustained above 10% for the full year across all operations, including the U.S. and India. Management remains optimistic for FY27, focusing on high-value 'build-to-spec' engagements and expansion into AI infrastructure and semiconductor supply chains.

Achieved a record order intake of over $208 million in FY26 with a book-to-bill ratio of 1.5x.
Sustained EBITDA margins at 10% plus for the full year across the entire global portfolio.
Successfully commenced series production for a semiconductor mission supply partner and new automotive lines.
Exports continue to drive the business, accounting for over 60% of total revenue.
Strategic shift towards 'build-to-spec' models to capture higher-value life cycle management opportunities.

💡 Investors should monitor the execution of the record order backlog which provides high revenue visibility for FY27. The company's successful margin expansion to double digits and entry into semiconductor supply chains are significant long-term growth catalysts.

Cyient DLM Schedules Investor Meeting with 3P Investments on April 28, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 23 Apr 2026, 05:32 PM

Cyient DLM Limited has announced a virtual meeting with 3P Investments scheduled for April 28, 2026, between 3:00 PM and 4:00 PM. The company will be represented by its top leadership, including MD & CEO Rajendra Velagapudi and CFO Subramanian RM. This meeting is part of the company's regular engagement with institutional investors to discuss business outlook. The company has explicitly stated that no unpublished price sensitive information (UPSI) will be shared during the interaction.

Virtual meeting scheduled with 3P Investments on April 28, 2026, at 3:00 PM.
High-level representation including MD & CEO Rajendra Velagapudi and CFO Subramanian RM.
The interaction is scheduled for a duration of 1 hour via virtual mode.
Compliance confirmation that no unpublished price sensitive information will be disclosed.

💡 Investors should monitor for any subsequent investor presentations or transcripts filed by the company for insights into management's outlook. No immediate trading action is required based on this routine disclosure.

Cyient DLM Releases Q4 and FY26 Earnings Call Recording

🟡 NEUTRAL ⭐ 4/10

EARNINGS 📅 22 Apr 2026, 09:01 AM

Cyient DLM Limited has officially released the audio recording of its earnings conference call held on April 21, 2026. The call focused on the company's financial performance for the fourth quarter and the full fiscal year ended March 2026. This disclosure is a routine regulatory requirement under SEBI LoDR Regulations to ensure transparency for all shareholders. Investors can now access the management's detailed commentary and Q&A session via the company's website.

Earnings conference call conducted on April 21, 2026, following Q4 and FY26 results.
Audio recording made available to the public via a dedicated URL and company website.
Compliance with Regulation 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Provides access to management's outlook and responses to institutional investor queries.

💡 Investors should listen to the recording to understand management's guidance on the order book and margin expansion for the next fiscal year. This is particularly useful for analyzing the company's performance in the electronics manufacturing services (EMS) sector.

Cyient DLM FY26 Results: Order Book Hits Record ₹2,416 Cr Despite 17% Revenue Decline

🔵 WATCH ⭐ 8/10

EARNINGS 📅 21 Apr 2026, 05:44 PM

Cyient DLM reported a challenging FY26 with annual revenue declining 17% YoY to ₹1,261.5 crores, though Q4 showed a strong sequential recovery of 21.7% QoQ. Despite top-line pressure, the company maintained double-digit EBITDA margins at 10.3% for the full year, an improvement of 78 bps YoY. The most significant positive is the record order book of ₹2,416.6 crores and a robust book-to-bill ratio of 1.5, indicating strong future revenue visibility. Profitability was supported by reduced finance costs and operational efficiencies, even as normalized PAT saw a slight decline.

FY26 Revenue fell 17% YoY to ₹1,261.5 Cr, but Q4 Revenue grew 21.7% QoQ to ₹369.1 Cr
Order Book reached a record high of ₹2,416.6 Cr with a strong Book-to-Bill ratio of 1.5 for the year
Normalized FY26 EBITDA margin improved by 78 bps to 10.3%, totaling ₹130.2 Cr
Reported PAT for FY26 stood at ₹73.3 Cr, aided by one-off income in Q2
Industrial and Medical segments contributed 46% of Q4 order intake, showing successful diversification

💡 Investors should monitor the conversion of the record order book into revenue in FY27 to confirm a growth turnaround. While the revenue decline is a concern, the margin expansion and strong order pipeline suggest long-term resilience.

Cyient DLM Q4 FY26: Record Order Book of ₹24,166 Mn Despite 13.8% Revenue Decline

🔵 WATCH ⭐ 8/10

EARNINGS 📅 21 Apr 2026, 05:13 PM

Cyient DLM reported a contraction in Q4 FY26 financials with revenue at ₹3,691 Mn (down 13.8% YoY) and PAT at ₹224 Mn (down 27.7% YoY), primarily due to the completion of large defense orders in the previous fiscal year. However, the company achieved a record-high order book of ₹24,166 Mn, reflecting a 15% QoQ growth and a strong book-to-bill ratio of 1.5x for the full year. Normalized EBITDA margins for FY26 improved to 10.3% from 9.6% YoY, driven by a better product mix and cost controls. The company is successfully diversifying, having started series production for automotive and semiconductor equipment manufacturing accounts.

Order book reached a record ₹24,166 Mn, growing 15% QoQ with a sustained book-to-bill ratio of 1.2 in Q4.
Q4 FY26 Revenue and PAT declined YoY by 13.8% and 27.7% respectively, following the completion of major A&D contracts.
Normalized FY26 EBITDA margin improved by 77 bps to 10.3%, despite a 17% decline in annual revenue.
Finance costs for Q4 fell by 34.4% YoY to ₹56 Mn due to lower interest rates and reduced working capital borrowings.
Achieved key milestones in new segments, including IATF certification for Automotive and series production for Semiconductor equipment.

💡 Investors should look past the temporary YoY revenue dip and focus on the record order book which provides strong visibility for FY27. The successful entry into Automotive and Semiconductor sectors suggests a positive shift in the revenue mix toward high-growth industries.

Cyient DLM FY26 Net Profit Rises 7.6% to ₹732.8M Despite 17% Revenue Decline

🔵 WATCH ⭐ 8/10

EARNINGS 📅 21 Apr 2026, 05:10 PM

Cyient DLM reported a consolidated net profit of ₹732.82 million for the full year FY26, marking a 7.6% growth over FY25, even as annual revenue from operations fell 17% to ₹12,614.85 million. The fourth quarter (Q4FY26) showed weakness with revenue declining 13.8% YoY to ₹3,690.77 million and PAT dropping 27.7% YoY to ₹224.41 million. The company fully utilized its IPO proceeds of ₹6,631.54 million by the end of the fiscal year. A notable fair value loss of ₹352.62 million was recorded in Other Comprehensive Income related to an IP-based communications investment.

Full-year FY26 Consolidated Net Profit increased to ₹732.82 million from ₹680.76 million in FY25.
Annual Revenue from operations declined 17% YoY to ₹12,614.85 million compared to ₹15,196.26 million.
Q4 FY26 Revenue fell 13.8% YoY to ₹3,690.77 million while PAT fell 27.7% YoY to ₹224.41 million.
Total IPO proceeds of ₹6,631.54 million have been 100% utilized as of March 31, 2026.
Recorded a ₹352.62 million fair value reduction in an IP investment due to long lead times in product development.

💡 Investors should exercise caution due to the significant decline in top-line revenue, despite the slight improvement in annual bottom-line margins. Monitor management commentary regarding the recovery of the IP investment and the pipeline for new order execution to reverse the revenue trend.

Cyient DLM to Host Q4 FY26 Earnings Conference Call on April 21, 2026

🟡 NEUTRAL ⭐ 4/10

EARNINGS 📅 16 Apr 2026, 12:51 PM

Cyient DLM Limited has scheduled its earnings conference call to discuss audited financial results for the fourth quarter and full year ended March 31, 2026. The call is set for Tuesday, April 21, 2026, at 6:00 PM IST. Senior management, including the MD & CEO and CFO, will be present to discuss performance and address investor queries. This follows the company's focus on providing integrated electronics manufacturing solutions for mission-critical applications.

Earnings conference call scheduled for April 21, 2026, at 06:00 PM IST.
Management participants include MD & CEO Rajendra Velagapudi and CFO Subramanian RM.
The call will cover audited financial results for both Q4 FY26 and the full fiscal year 2026.
Dial-in details provided for universal access and international toll-free numbers for USA, UK, Singapore, and Hong Kong.

💡 Investors should track the financial results release on April 21 and listen to the call for management commentary on order book growth and margin sustainability. Key focus areas should be the company's performance in highly regulated industries like aerospace and defense.

Cyient DLM Announces Trading Window Closure from April 1, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 31 Mar 2026, 12:05 PM

Cyient DLM Limited has informed the exchanges that its trading window for transacting in company securities will be closed starting April 1, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations for the financial year ending March 31, 2026. The window will remain shut until 48 hours after the public dissemination of the company's annual financial results. This is a standard regulatory procedure intended to prevent insider trading prior to the release of price-sensitive financial information.

Trading window closure effective from April 1, 2026, for all designated persons.
Closure relates to the audit and declaration of financial results for the year ended March 31, 2026.
The window will reopen 48 hours after the official announcement of the financial results.
Compliance maintained under SEBI (Prohibition of Insider Trading) Regulations, 2015.

💡 No action is required as this is a routine regulatory filing. Investors should look forward to the upcoming FY26 earnings release for a better understanding of the company's financial health.

Cyient DLM Shareholders Approve Variation in IPO Proceeds Utilization with 99.99% Majority

🟡 NEUTRAL ⭐ 7/10

REGULATORY 📅 09 Mar 2026, 01:28 PM

Cyient DLM shareholders have passed a special resolution to vary the objects and terms of utilization of the company's Initial Public Offering (IPO) proceeds. The resolution also includes an extension of the time limit for utilizing these funds, providing the company with greater operational flexibility. The proposal received overwhelming support, with 99.99% of the total votes cast in favor. This approval allows the management to reallocate capital or adjust timelines based on current business requirements and market conditions.

Special resolution passed to vary IPO objects and extend the utilization timeline for proceeds.
The resolution received 99.9967% approval, with 63,704,092 votes in favor and only 2,104 against.
100% of the promoter group (41,366,502 votes) and 100% of public institutions (22,290,857 votes) supported the move.
The voting process was conducted via remote e-voting from February 7 to March 8, 2026.
A total of 63.7 million valid votes were cast out of a shareholder base of 104,162.

💡 Investors should monitor the company's future disclosures to understand the specific changes in how the IPO funds will now be deployed. The near-unanimous institutional support suggests confidence in the management's revised capital allocation strategy.

Cyient DLM Schedules Investor Meeting with Unifi Capital for March 11, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 05 Mar 2026, 04:43 PM

Cyient DLM Limited has announced a scheduled meeting with Unifi Capital on March 11, 2026. The meeting is set to take place between 10:00 AM and 12:00 PM in a hybrid format, including both face-to-face and virtual interactions. Senior management, including MD & CEO Rajendra Velagapudi and AVP Suresh Narayan, will represent the company. The company has explicitly stated that no unpublished price sensitive information (UPSI) will be shared during this interaction.

Meeting scheduled with Unifi Capital on March 11, 2026, from 10:00 AM to 12:00 PM
Top management representation including MD & CEO Rajendra Velagapudi
Interaction to be conducted via hybrid mode (Face-to-Face and Virtual)
Compliance filing under SEBI (LODR) Regulation, 2015
Company confirms no unpublished price sensitive information will be disclosed

💡 This is a routine regulatory disclosure. Investors should look for any subsequent investor presentations or transcripts that may provide qualitative insights into the company's operational outlook.

Cyient DLM to Meet Top Institutional Investors at Axis Capital Conference on Feb 11, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 07 Feb 2026, 10:49 AM

Cyient DLM Limited has announced its participation in the 'Advantage India' conference hosted by Axis Capital in Mumbai on February 11, 2026. The company's top leadership, including the MD & CEO and CFO, will engage in one-on-one and group meetings with over 25 major institutional investors. Key participants include HDFC Mutual Fund, Nippon India Mutual Fund, ICICI Prudential, and Tata Mutual Fund. These meetings are part of routine investor relations and will not involve sharing unpublished price-sensitive information.

Scheduled participation in Axis Capital's Flagship India Conference on February 11, 2026, in Mumbai.
One-on-one meetings confirmed with HDFC MF, Nippon India MF, and Axis Max Life Insurance.
Group interactions scheduled with over 20 marquee funds including Abakkus, Aditya Birla AMC, and Mirae MF.
Top management representation including MD & CEO Rajendra Velagapudi and CFO RM Subramanian.

💡 Investors should monitor for any investor presentations or post-meet disclosures that may provide updated insights into the company's growth strategy. The significant interest from top-tier mutual funds and PMS houses indicates strong institutional focus on the stock.

Cyient DLM to reallocate ₹36.85 crore of IPO proceeds to working capital

🟡 NEUTRAL ⭐ 7/10

FUNDRAISE 📅 06 Feb 2026, 07:34 PM

Cyient DLM is seeking shareholder approval via a postal ballot to modify the utilization of its IPO proceeds. The company proposes to reallocate ₹36.85 crore originally earmarked for Capital Expenditure to meet incremental Working Capital requirements. Additionally, the timeline for the utilization of these funds has been extended to Fiscal Year 2026-27. This move indicates a strategic shift toward prioritizing operational liquidity over immediate fixed asset investments.

Reallocation of ₹36.85 crore from Capital Expenditure to Working Capital requirements
Revised Working Capital allocation increased to ₹327.94 crore from the original ₹291.09 crore
Capital Expenditure budget significantly reduced to ₹6.72 crore following the transfer
Utilization timeline for remaining IPO proceeds extended through Fiscal Year 2026-27
General Corporate Purposes budget increased by ₹4.20 crore due to lower-than-expected IPO issue expenses

💡 Investors should evaluate whether the shift toward working capital reflects higher inventory requirements or slower-than-expected execution of capital projects. Monitor the upcoming voting results and management's commentary on the revised growth timeline.

Cyient DLM Q3 FY26: Strong Order Intake of ₹387 Cr and 1.3 Book-to-Bill Ratio

🔵 WATCH ⭐ 8/10

EARNINGS 📅 27 Jan 2026, 02:51 PM

Cyient DLM reported a robust order intake of ₹387 crores in Q3 FY26, achieving a book-to-bill ratio of 1.3 for the quarter and 1.56 YTD. While revenue was soft due to holiday-related push-outs and tariff uncertainties, management expects these shipments to recover in Q4. The company maintained double-digit EBITDA margins, though results were impacted by one-time labor code adjustments and aborted M&A-related expenses. Strategic focus remains on high-margin Build-to-Spec (B2S) programs and expansion into European and defense markets.

Reported a healthy order intake of ₹387 crores with a book-to-bill ratio of 1.3 for the quarter.
Year-to-date (YTD) book-to-bill ratio stands strong at 1.56, providing high revenue visibility for coming quarters.
Added 2 new strategic logos in the medical and industrial sectors and commenced revenue from B2S programs.
EBITDA margins were impacted by one-time costs related to a new labor code and expenses from a non-materialized M&A deal.
Management noted revenue softness was temporary, driven by customer wait-and-watch modes regarding global tariff uncertainties.

💡 Investors should monitor the execution of the ₹387 crore order book in Q4 to confirm that the Q3 revenue softness was indeed temporary. The increasing mix of Build-to-Spec (B2S) and defense contracts suggests long-term margin expansion potential.

View All CYIENTDLM Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Consolidated revenue grew 44% YoY to INR 1,196 Cr in FY24, followed by 27.4% growth to INR 1,524 Cr in FY25. Growth is primarily driven by the Aerospace and Defense segments, which saw strong order execution. H1 FY24 revenue specifically grew 50% YoY to INR 509 Cr.

Geographic Revenue Split

The United States contributes approximately 25% of total revenue (excluding the Altek facility). The company also serves clients in Europe, North America, India, China, and Japan.

Profitability Margins

PAT margin was 5.1% in FY24 (INR 61 Cr) and moderated to 3.6% in FY25 (INR 68 Cr). Normalized PAT margin in Q2 FY26 was reported at 4%, though reported PAT was higher at 10.3% due to a one-time gain from performance conditions not being met in the Altek acquisition.

EBITDA Margin

EBITDA margin was 9.3% in FY24, a decrease from 11-12% in FY23. Q1 FY25 margin was 7.8%. The moderation is attributed to a substantial increase in employee headcount, ESOP expenses, and the delivery of a large low-margin order. The company targets a return to double-digit margins (10-11%) through better fixed cost absorption.

Capital Expenditure

The company utilized INR 700 Cr from IPO proceeds for debt repayment, working capital, and capital investments. The acquisition of Altek Electronics Inc was valued at approximately INR 248 Cr ($29.2 million), funded through INR 103 Cr of foreign exchange debt, INR 70 Cr from IPO proceeds, and internal accruals.

Credit Rating & Borrowing

CRISIL A+/Positive for un-guaranteed facilities and CRISIL AA/Stable for facilities guaranteed by Cyient Ltd. The company maintains a net external debt-free status post-IPO, utilizing low-cost foreign exchange debt for acquisitions.

⚙️ Operational Drivers

Raw Materials

Specific materials include printed circuit boards (PCBs), electronic components, and subsystems for high-tech engineering, representing the bulk of the manufacturing cost base.

Import Sources

Sourced globally to support manufacturing units in India and the United States (via Altek facility in Connecticut).

Key Suppliers

Not specifically named in available documents; however, the company operates as a partner to major OEMs in Aerospace, Defense, and Medical sectors.

Capacity Expansion

Current capacity supports an order book of INR 2,127 Cr as of June 2024. Expansion is driven by the Altek acquisition in the US and enhanced hiring in FY24 to cater to medium-term demand.

Raw Material Costs

Raw material costs are susceptible to price fluctuations; the company manages this through an ongoing shift to higher-margin orders and benefits of operating leverage as scale increases.

Manufacturing Efficiency

Efficiency is driven by the 'design-led manufacturing' model, which integrates Cyient Ltd's engineering designs into production, improving fixed cost absorption as revenue scales toward INR 1,500 Cr+.

📈 Strategic Growth

Expected Growth Rate

30-40%

Growth Strategy

Growth will be achieved through the execution of a healthy order book (INR 2,127 Cr as of June 2024), the full-year integration of Altek Electronics (which contributed INR 174.66 Cr in FY25), and expanding the 'design-to-production' synergy with parent company Cyient Ltd. The company is focusing on high-margin export orders and new product mass manufacturing.

Products & Services

System design, integration, testing, and manufacturing of electronic components, subsystems, and printed circuit board assemblies (PCBA) for Aerospace, Defense, Medical, and Industrial OEMs.

Brand Portfolio

Cyient DLM.

New Products/Services

Expansion into the semiconductor business and complete engineering solutions (design-to-production) in collaboration with Cyient Ltd.

Market Expansion

Aggressive expansion into the US market via the Altek acquisition and increasing domestic sales in India driven by defense sector demand.

Market Share & Ranking

Not disclosed in available documents, but described as a 'moderate scale' player with revenues under INR 1,500 Cr.

Strategic Alliances

Strong parental support from Cyient Ltd, which holds a 52.12% stake as of June 2025 and provides managerial and financial backing.

🌍 External Factors

Industry Trends

The EMS (Electronic Manufacturing Services) industry is seeing a shift toward design-integrated manufacturing. Cyient DLM is positioning itself to provide end-to-end solutions rather than just assembly, moving from 15% historical growth to 30-40% projected growth.

Competitive Landscape

Competes with other Tier-II IT and EMS providers; market dynamics are currently impacted by industry-wide stock price volatility (38.6% dip in early 2025).

Competitive Moat

The primary moat is the synergy with Cyient Ltd's Engineering Research and Development (ER&D) services, allowing for a 'design-to-production' value proposition that is difficult for pure-play EMS providers to replicate.

Macro Economic Sensitivity

Sensitive to global aerospace and defense spending and US trade policies/tariffs.

Consumer Behavior

Shift in OEM behavior toward seeking partners who can handle both design and manufacturing to reduce supply chain complexity.

Geopolitical Risks

Exposure to US-China trade tensions; mitigated by acquiring a local US manufacturing unit (Altek) to handle US-based demand.

⚖️ Regulatory & Governance

Industry Regulations

Subject to stringent Aerospace and Defense manufacturing standards and US import/export tariffs which are currently a key monitorable.

Legal Contingencies

Goodwill of INR 63.84 Cr from acquisitions is being amortized over five years starting FY25. No specific pending court cases with values were disclosed.

⚠️ Risk Analysis

Key Uncertainties

Potential for 20-30% margin volatility if product mix shifts back to low-margin orders or if employee costs continue to rise faster than fixed cost absorption.